Selective beta-adrenoceptor agonists, calcium antagonists and potassium channel openers as a possible medical treatment of the overactive bladder and urge incontinence

Pharmazie

Volumn 61, Issue 3, 2006, Pages 175-178

  Badawi, J K ^a   Langbein, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; A 278637; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETHANECHOL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLENBUTEROL; CROMAKALIM; DILTIAZEM; MINOXIDIL; MUSCARINIC RECEPTOR BLOCKING AGENT; NIFEDIPINE; NIMODIPINE; OXYBUTYNIN; PINACIDIL; POTASSIUM CHANNEL STIMULATING AGENT; PROCATEROL; TOLTERODINE; TROSPIUM CHLORIDE; UNCLASSIFIED DRUG; VERAPAMIL;

ADRENERGIC ACTIVITY; BLURRED VISION; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONSTIPATION; DRUG EFFECT; DRUG INHIBITION; HEALTH CARE COST; HUMAN; HYPOTENSION; MEMBRANE CHANNEL; MUSCLE RELAXATION; NONHUMAN; OVERACTIVE BLADDER; REVIEW; TACHYCARDIA; UNSPECIFIED SIDE EFFECT; URGE INCONTINENCE; URINE INCONTINENCE; XEROSTOMIA;

ADRENERGIC BETA-AGONISTS; CALCIUM CHANNEL BLOCKERS; HUMANS; POTASSIUM CHANNELS; URINARY BLADDER, NEUROGENIC; URINARY INCONTINENCE;

EID: 33645371508     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Abernethy DR, Schwartz JB (1999) Calcium-antagonist drugs. N Engl J Med 341: 1447-1457.
2. Andersson KE (1992) Clinical pharmacology of potassium channel openers Pharmacol Toxicol 70: 244-254.
3. Andersson KE (2000) Mode of action of alpha1-adrenoreceptor antagonists in the treatment of lower urinary tract symptoms. BJU Int 85 (Suppl 2): 12-18.
4. Badawi JK, Langbein S (2005) Current diagnostics and therapy of the overactive bladder and urge incontinence. Dtsch Med Wochenschr 130: 1503-1506.
5. Badawi JK, Uecelehan H, Hatzinger M, Michel MS, Haferkamp A, Bross S (2005) Relaxant effects of beta-adrenergic agonists on porcine and human detrusor muscle. Acta Physiol Scand 185: 151-159.
6. Barany M (1996) Biochemistry of Smooth Muscle Contraction Chapter 16: Calcium Channels and Potassium Channels. Academic Press: 367-374.
7. Brune ME, Fey TA, Brioni JD, Sullivan JP, Williams M, Carroll WA, Coghlan MJ, Gopalakrishnan M (2002) (-)-(95)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin(1996)-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. II. In vivo characterization. J Pharmacol Exp Ther 303: 387-394.
8. Cox DH, Cui J, Aldrich RW (1997) Allosteric gating of a large conductance Ca-activated K+ channel. J Gen Physiol 110: 257-281.
9. Criddle DN, de Moura RS (2000) Vasorelaxant effects of the potassium channel opener SR 47063 on the isolated human saphenous vein and rat aorta. Brazil J Med Biol Res 33: 961-966.
10. Elliott RA, Norman RI, Parker SG, Whitaker RP, Castleden CM (1996) Effect of treatment with calcium antagonists in vitro and in vivo on the contractile response of isolated rat and human detrusor muscle. Clin Sci (Lond) 91: 467-474.
11. Foster CD, Speakman MJ, Fujii K, Brading AF (1989) The effects of cromakalim on the detrusor muscle of human and pig urinary bladder. Br J Urol 63: 284-294.
12. Fry CH, Skennerton D, Wood D, Wu C (2002) The cellular basis of contraction in human detrusor smooth muscle from patients with stable and unstable bladders. Urology 59(5 Suppl 1): 3-12.
13. Gotoh M, Kondo A, Mitsuya H (1987) Inhibitory effect of a calcium entry blocker (verapamil) on detrusor muscle contractility: feasibility of clinical application. Hinyokika Kiyo 33: 357-363.
14. Grueneberger A, Geier G (1981) Die Therapie der motorischen Reizblase mit dem beta 2-Sympathomimetikum Clenbuterol. Urologe A 20: 153-154.
15. Grueneberger A (1984) Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride. Br J Obstet Gynaecol 91: 275-278.
16. Hassouna M, Nishizawa O, Miyagawa I, Toguri A, Gotoh M, Elhilali M (1986) Role of calcium ion antagonists of the bladder detrusor muscle: in vitro and in vivo study. J Urol 135: 1327-1331.
17. Hautmann R, Huland H (2001) Urologie. Springer-Verlag.
18. Herrera GM, Heppner TJ, Nelson MT (2000) Regulation of urinary bladder smooth muscle contractions by ryanodine receptors and BK and SK channels. Am J Physiol Regul Integr Comp Physiol 279: R60-68.
19. Herrera GM, Nelson MT (2002) Differential regulation of SK and BK channels by Ca(2+) signals from Ca(2+) channels and ryanodine receptors in guinea-pig urinary bladder myocytes. J Physiol 541(Pt 2): 483-492.
20. Hu T (2004) Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology 63: 461-465.
21. Igawa Y, Yamazaki Y, Takeda H, Hayakawa K, Akahane M, Ajisawa Y, Yoneyama T, Nishizawa O, Andersson KE (1999) Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle. Br J Pharmacol 126: 819-825.
22. Igawa Y, Yamazaki Y, Takeda H, Kaidoh K, Akahane M, Ajisawa Y, Yoneyama T, Nishizawa O, Andersson KE (2001) Relaxant effects of isoproterenol and selective beta3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders. J Urol 165: 240-244.
23. Kato K, Kitada S, Chun A, Wein AJ, Levin RM (1989) In vitro intravesical instillation of anticholinergic, antispasmodic and calcium blocking agents (rabbit whole bladder model). J Urol 141: 1471-1475.
24. Komersova K, Rogerson JW, Conway EL, Lim TC, Brown DJ, Krum H, Jackman GP, Murdoch R, Louis WJ (1995) The effect of levcromakalim (BRL 38227) on bladder function in patients with high spinal cord lesions. Br J Clin Pharmacol 39: 207-209.
25. Li JH, Yasay GD, Kau ST (1992) Beta-adrenoceptor subtypes in the detrusor of guinea-pig urinary bladder. Pharmacology 44: 13-18.
26. Longhurst PA, Levendusky M (1999) Pharmacological characterization of beta-adrenoceptors mediating relaxation of the rat urinary bladder in vitro. Br J Pharmacol 127: 1744-1750.
27. Lynch JJ 3rd, Brune ME, Lubbers NL, Coghlan MJ, Cox BF, Polakowski JS, King LL, Sullivan JP, Brioni JD (2003) K-ATP opener-mediated attenuation of spontaneous bladder contractions in ligature-intact, partial bladder outlet obstructed rats. Life Sci 72: 1931-1941.
28. Masuda N, Uchida W, Shirai Y, Shibasaki K, Goto K, Takenaka T (1995) Effect of the potassium channel opener YM934 on the contractile response to electrical field stimulation in pig detrusor smooth muscle. J Urol 154: 1914-1920.
29. Mattiasson A, Ekstrom B, Andersson KE (1989) Effects of intravesical instillation of verapamil in patients with detrusor hyperactivity. J Urol 141: 174-177.
30. Meredith AL, Thorneloe KS, Werner ME, Nelson MT, Aldrich RW (2004) Overactive bladder and incontinence in the absence of the BK large conductance Ca2+-activated K+ channel. J Biol Chem 279: 36746-36752.
31. Naglie G, Radomski SB, Brymer C, Mathiasen K, O'Rourke K, Tomlinson G (2002) A randomized, double-blind, placebo controlled crossover trial of nimodipine in older persons with detrusor instability and urge incontinence. J Urol 167: 586-590.
32. Rizk DE, Arafat K, El-Sharkawy TY (2001) Comparison of the inhibitory effects of cromakalim and pinacidil (potassium channel openers) with those of oxybutynin on stimulated guinea pig and rabbit detrusor muscle strips. Arch Gynecol Obstet 265: 141-147.
33. Takeda M, Obara K, Mizusawa T, Tomita Y, Arai K, Tsutsui T, Hatano A, Takahashi K, Nomura S (1999) Evidence for beta3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods. J Pharmacol Exp Ther 288: 1367-1373.
34. Takeda H, Matsuzawa A, Igawa Y et al. (2003) Functional characterization of beta-adrenoceptor subtypes in the canine and rat lower urinary tract. J Urol 170(2 Pt 1), 654-658.
35. Tsien RW, Lipscombe D, Madison DV, Bley KR, Fox AP (1988) Multiple types of neuronal calcium channels and their selective modulation. Trend Neurosci 11: 431-438.
36. Weiss R, Mevissen M, Hauser DS, Scholtysik G, Portier CJ, Walter B, Studer UE, Danuser H (2002) Inhibition of human and pig ureter motility in vitro and in vivo by the K(+) channel openers PKF 217-744b and nicorandil. J Pharmacol Exp Ther 302: 651-658.
37. Yamaguchi O (2002) Beta3-adrenoceptors in human detrusor muscle. Urology 59(5 Suppl 1): 25-29.
38. Yamazaki Y, Takeda H, Akahane M, Igawa Y, Nishizawa O, Ajisawa Y (1998) Species differences in the distribution of beta-adrenoceptor subtypes in bladder smooth muscle. Br J Pharmacol 124: 593-599.
39. Yarker YE, Goa KL, Fitton A (1995) Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs Aging 6: 243-262.